The Latest Breaking News from Clinical Trial

In a recent study published in Frontiers in Medicine, researchers showed that "almost 90% of patients with dementia suffer from some type of neurobehavioral symptom, and there are no approved medications to addr

But positive clinical trial results also renew the hopes of millions of seniors.

Alberta-based ATMA Journey Centers Inc.

Lucy Bromley was diagnosed with an incurable brain tumour earlier this year. Her family is trying to raise money to enrol her in an experimental clinical trial.

Identifying and addressing the barriers to enrolling in research that patients face can increase participation and lead to better patient care.

Stephen Wadey was diagnosed with melanoma seven years ago. After surgery to remove the cancer, he decided to join a clinical trial — despite the huge distance.

The U.S. Food and Drug Administration (FDA) has granted fast track designation for the development of TRACON’s (NASDAQ:TCON) lead asset envafolimab (KN035) for patients with locally advanced, unresectable or metastatic undifferentiated pleomorphic sarcoma (UPS) and myxofibrosarcoma (MFS) who have progressed on one or two prior lines of chemotherapy. TRACON shares…

Akero Therapeutics (NASDAQ:AKRO) revealed topline data from HARMONY, a 24-week Phase 2b study evaluating the efficacy and safety of its lead product candidate efruxifermin (EFX) in patients with pre-cirrhotic nonalcoholic steatohepatitis (NASH), the study met its primary endpoint for both the 50mg and 28mg EFX dose groups. Akero Therapeutics shares…

The U.S. Food and Drug Administration (FDA) has approved Spectrum Pharmaceuticals’ (NASDAQ:SPPI) lead asset ROLVEDON (eflapegrastim-xnst) injection to decrease the incidence of infection, as manifested by febrile neutropenia. Spectrum Pharmaceuticals shares traded as high as 3.17 percent, in a range of $1.21 to $1.30 on day volume of 6.8 million…